AKT1 and depressive disorder: Akt (a target of PI3K) acts as a pivot position in the treatment of depression through connecting with downstream targets, including glycogen synthase kinase-3 beta (GSK3β), mammalian target of rapamycin, IκB kinaseα, γ-aminobutyric acid A receptor, and forkhead box O, which are involved in the regulation of glucose and lipid metabolism, synaptic plasticity, angiogenesis, proliferation and apoptosis, synaptic signaling, and mitochondrial function.